MARKET

INO

INO

Inovio Pharmaceu
NASDAQ
9.68
-0.52
-5.10%
After Hours: 9.51 -0.17 -1.76% 18:39 04/19 EDT
OPEN
10.20
PREV CLOSE
10.20
HIGH
10.20
LOW
9.54
VOLUME
353.70K
TURNOVER
0
52 WEEK HIGH
14.75
52 WEEK LOW
3.888
MARKET CAP
226.23M
P/E (TTM)
-1.5886
1D
5D
1M
3M
1Y
5Y
Why Skillsoft Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Sk Skillsoft Corp. Shares dipped 26.7% to $6.74 on Tuesday. The company reported mixed fourth-quarter financial results and issued FY25 revenue guidance below estimates. WiSA Technologies, Inc. Shares jumped 85% after the company announced a licensing agreement with an HDTV/PTV brand.
Benzinga · 3d ago
Inovio Pharmaceuticals Stock Is Diving Today: What's Happening?
Inovio Pharmaceuticals Inc. Announced the pricing of a public offering of 2,536,258 shares of its common stock. The company anticipates gross proceeds of approximately $36 million. Inovio is a biotechnology company focused on developing and commercializing DNA medicines.
Benzinga · 4d ago
Why Macatawa Bank Shares Are Trading Higher By Around 37%; Here Are 20 Stocks Moving Premarket
Shares of Macatawa Bank Corporation rose sharply in today’s pre-market trading after the company announced a merger agreement with Wintrust Financial Corporation. Dynatronics Corporation shares rose 69.8% to $0.6301 in pre- market trading. Groupon, Inc. Shares fell 8.9% in today's trading.
Benzinga · 4d ago
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Dynatronics (NASDAQ:DYNT) stock rose 84.9% to $0.69 during Tuesday's pre-market session. The company's market cap rose to $3.3 million. Inovio Pharmaceuticals shares fell 24.3% during the session. Akanda shares increased by 23.0% and BioRestorative Therapies shares moved upwards.
Benzinga · 4d ago
Inovio falls after pricing stock offering
Inovio Pharmaceuticals, Inc. Lost 21% premarket Tuesday. DNA medicine developer priced an underwritten offering of its common stock below its currently traded price. Plymouth Meeting, a Pennsylvania-based biotech, intends to raise $36M in gross proceeds from the offering.
Seeking Alpha · 4d ago
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Dynatronics stock is rocketing more than 97% alongside heavy pre-market trading on Tuesday morning. Dragonfly Energy shares are soaring 55% after releasing its Q4 2023 earnings report. The biggest pre- market stock movers on Tuesday include Dynatronics and an acquisition agreement.
Investorplace · 4d ago
Live Nation Entertainment, Groupon And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Shares of Live Nation Entertainment, Inc. Fell sharply in today’s pre-market trading. The Justice Department is expected to file an antitrust lawsuit against the company. The Dow futures were mixed this morning, with the Dow gaining around 100 points. Groupon and Lyell Immunopharma were among the big stocks recording losses in today's pre- market trading.
Benzinga · 4d ago
Reported Earlier, INOVIO Prices $36M Underwritten Offering Of 2,536,258 Common Stock At $7.693/Share
INOVIO Pharmaceuticals announced the pricing of an underwritten offering of 2,536,258 shares of its common stock. The company says the stock will be sold at a price of $7.693 per share in a public offering. The company is a maker of injectable pharmaceuticals.
Benzinga · 4d ago
More
About INO
Inovio Pharmaceuticals, Inc. is a clinical-stage biotechnology company. The Company is focused on developing and commercializing deoxyribonucleic acid (DNA) medicines to help treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines pipeline include INO-3107 for HPV-related recurrent respiratory papillomatosis (RRP); INO-3112 for the treatment of HPV-related Oropharyngeal Squamous Cell Carcinoma, or OPSCC; VGX-3100 for the treatment of Anal or Perianal HSIL; INO-5401 for the treatment of Glioblastoma Multiforme (GBM), and INO-5401 for the Treatment of Glioblastoma Multiforme (GBM). Its lead candidate is INO-3107 for the treatment of RRP, a rare and debilitating disease of the respiratory tract caused by HPV infection. Its DNA medicines platform consists of DNA plasmids and its CELLECTRA devices, which are used to deliver the DNA plasmids into the cell. Its CELLECTRA device portfolio consists of two models.

Webull offers Inovio Pharmaceuticals Inc stock information, including NASDAQ: INO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, INO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading INO stock methods without spending real money on the virtual paper trading platform.